Zobrazeno 1 - 6
of 6
pro vyhledávání: '"M R, McCredie"'
Autor:
G A, Huttley, S, Easteal, M C, Southey, A, Tesoriero, G G, Giles, M R, McCredie, J L, Hopper, D J, Venter
Publikováno v:
Nature genetics. 25(4)
Mutations in BRCA1 (ref. 1) confer an increased risk of female breast cancer. In a genome-wide scan of linkage disequilibrium (LD), a high level of LD was detected among microsatellite markers flanking BRCA1 (ref. 3), raising the prospect that positi
BACKGROUND: Whether phenacetin-containing analgesics cause renal pelvic tumors by virtue of the weak mutagenicity of phenacetin, or indirectly through local effects of analgesic-induced renal papillary scarring, is debated. Because phenacetin consump
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::b64e75118fc6ec71129906cc37a7a124
https://hdl.handle.net/2123/30758
https://hdl.handle.net/2123/30758
Autor:
J L, Hopper, M C, Southey, G S, Dite, D J, Jolley, G G, Giles, M R, McCredie, D F, Easton, D J, Venter
The average breast cancer risk for carriers of a germ-line mutation in BRCA1 or BRCA2 (penetrance) has been estimated from the multiple-case families collected by the Breast Cancer Linkage Consortium (BCLC) to be approximately 80% to age 70. However,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::e7de5d54b774d19e3fb26508c7ac16c0
http://cebp.aacrjournals.org/content/8/9/741
http://cebp.aacrjournals.org/content/8/9/741
Autor:
J E, Armes, A J, Egan, M C, Southey, G S, Dite, M R, McCredie, G G, Giles, J L, Hopper, D J, Venter
Publikováno v:
Cancer. 83(11)
Women with breast carcinoma diagnosed before age 40 years have a greater prevalence of germline BRCA1 and BRCA2 mutations than women with breast carcinoma diagnosed at older ages. Several recognizable histologic characteristics have been identified i
Autor:
M C, Southey, L, Batten, C R, Andersen, M R, McCredie, G G, Giles, G, Dite, J L, Hopper, D J, Venter
Publikováno v:
International journal of cancer. 79(5)
There has been recent interest in the risk of various cancers in cystic fibrosis (CF) patients and carriers of cystic fibrosis transmembrane conductance regulator (CFTR) mutations. It has been proposed that a CFTR mutation may protect against breast
Publikováno v:
Cancer causescontrol : CCC. 9(2)
A case-control-family study of breast cancer in women under the age of 40 was carried out in Melbourne and Sydney, Australia, from 1992 to 1995 to determine the risk factors for these women. Subjects included 467 incident cases identified by state ca